TARRYTOWN, N.Y., April 29, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the first quarter of 2025 and provided a business update.
Regeneron Reports First Quarter 2025 Financial and Operating Results
Seeking Alpha / 1 hour ago 1 Views
Comments